Salvianolic acid A protects human SH-SY5Y neuroblastoma cells against H2O2-induced injury by increasing stress tolerance ability

https://doi.org/10.1016/j.bbrc.2012.04.021Get rights and content

Abstract

Salvianolic acid A (Sal A) is a polyphenol extracted from the root of the Salvia miltiorrhiza bunge. Hydrogen peroxide (H2O2) is a major reactive oxygen species (ROS), which has been implicated in stroke and other neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease. In this study, we investigated the neuroprotective effects of Sal A in human SH-SY5Y neuroblastoma cells against H2O2-induced injury. Our results showed that cells pretreated with Sal A exhibited enhanced neuronal survival and that this protection was associated with an increase in adenosine triphosphate (ATP) and the stabilization of mitochondrial membrane potential. In addition, Sal A markedly decreased the excessive activation AMP-activated protein kinase (AMPK) and the serine–threonine protein kinase, Akt, in SH-SY5Ycells induced by H2O2. In conclusion, our results demonstrated that Sal A protects SH-SY5Y cells against H2O2-induced oxidative stress and these protective effects are related to stress tolerance and not energy depletion via inhibition of the AMPK and Akt signaling pathway.

Highlights

► Sal A inhibits the activation of AMPK. ► Sal A inhibits the activation of Akt. ► The protective effects of Sal A are related to stress tolerance via inhibition of AMPK and Akt.

Introduction

Salvianolic acid A (Sal A) is a polyphenol extracted from the root of Salvia miltiorrhiza bunge (also known as Danshen), which has been used for treatment of ischemic cardiocerebral vascular diseases thousands of years in China [1]. Growing evidence suggests that Sal A may account for the cardiocerebral protective properties of Danshen [2], [3], [4], [5], [6]. Recently, several molecular mechanisms of Sal A pharmacological activity have been investigated. Currently, several studies have revealed that Sal A plays an important role in a variety of cellular activities, including potent antioxidant activity [7], anti-apoptotic activity [8], improving rCBF [9] and anti-inflammatory effects [10], among others. Sal A has also been shown to function as a natural inhibitor of protein–protein interactions mediated by Src-family SH2 domains [11]. Moreover, Sal A can inhibit platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase [12]. Furthermore, Sal A suppresses the lipopolysaccharide-induced NF-kappaB signaling pathway by targeting IKKbeta [10]. Although our understanding of the role of Sal A in several diseases has grown over the past few years, further insight into the effects and mechanisms of Sal A is needed to utilize Danshen’s therapeutic potential to treat ischemic cardiocerebral vascular diseases.

Reactive oxygen species (ROS) have been hypothesized to play an important role in the coordinated cellular signaling [13]. The H2O2 ROS plays a crucial role during neuronal cell death in stroke and other neurodegenerative conditions [7], [14]. Human SH-SY5Y neuroblastoma cells are widely used as an experimental cell system for the study of neuronal cell damage [14], [15]. In this study, we evaluated H2O2-induced damage to human SH-SY5Y neuroblastoma cells to examine the protective effects of Sal A.

The AMP-activated protein kinase (AMPK), a serine threonine kinase, is a key metabolic and stress sensor/effector [16]. Growing evidence indicates that the serine–threonine protein kinase, Akt (also referred to as protein kinase B, PKB), is an important mediator of cell survival. Several reports indicate that Akt plays a key role in a broad spectrum of vital cellular functions [17], [18]; thus, it is important to analyze the role of Akt in a given model and environment. However, the effects of Sal A on AMPK and Akt levels in neurocyte damage have not yet been reported.

Sal A possesses one of the most important cardiocerebral protective properties of Danshen. We investigated the neuroprotective effects mechanisms of Sal A, with regard to cell viability, ATP content, mitochondrial membrane potential and the expression of AMPK and Akt during H2O2-induced injury in SH-SY5Y cells.

Section snippets

Cell culture and treatments

Human SH-SY5Y neuroblastoma cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) and F-12 (GIBCO, Gaithersburg) supplemented with 10% fetal bovine serum (FBS, Hyclone) in a humidified atmosphere of 5% CO2 and 95% air at 37 °C. The media was replaced every 2 days. Prior to the experiments, the SH-SY5Y cells were plated in 96-well plates at a density of approximately 1.5 × 104 cells per well (for MTT, ATP and mitochondrial membrane potential assays) and in 6-well plates at 8 × 106 cells

The effects of Sal A on the viability of SH-SY5Y cells exposed to H2O2

To determine the optimal concentration of H2O2, SH-SY5Y cells were cultured with varying concentrations of H2O2 for 24 h. Because our results showed a decreased level of the OD value (by 71%) after treatment with 200 μM of H2O2 (Fig. 1A), we selected a 24-h treatment of 200 μM H2O2 for subsequent experiments in the present study. As shown in Fig. 1B, the viability of the SH-SY5Y cells exposed to 200 μM H2O2 for 24 h was reduced compared with the normal group. In addition, co-treatment with Sal A

Discussion

In this study, we investigated the effects of Sal A on the injury of SH-SY5Y cells induced by H2O2. The decreasing survival rates of SH-SY5Y cells induced by H2O2 were increased after treatment with Sal A, and this protection was associated with the increased production of ATP and stabilization of the mitochondrial membrane potential. These findings indicated a protective effect of Sal A on H2O2-induced injury of SH-SY5Y cells, which is consistent with previous studies [8], [19].

Based on

References (36)

  • S. Janelidze et al.

    Alterations of Akt1 (PKBalpha) and p70(S6K) in transient focal ischemia

    Neurobiol. Dis.

    (2001)
  • M. Shibata et al.

    Upregulation of Akt phosphorylation at the early stage of middle cerebral artery occlusion in mice

    Brain Res.

    (2002)
  • J. Ruffels et al.

    Activation of ERK1/2, JNK and PKB by hydrogen peroxide in human SH-SY5Y neuroblastoma cells: role of ERK1/2 in H2O2-induced cell death

    Eur. J. Pharmacol.

    (2004)
  • L.D. McCullough et al.

    Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke

    J. Biol. Chem.

    (2005)
  • J.C. Dong et al.

    Beneficial effects of acetylsalvianolic acid A on focal cerebral ischemic rats subjected to middle cerebral artery thrombosis

    Yao Xue Xue Bao.

    (1996)
  • G.H. Du et al.

    Protective effects of salvianolic acid A against impairment of memory induced by cerebral ischemia-reperfusion in mice

    Chin. Med. J.

    (1997)
  • T. Wang et al.

    Salvianolic acid A exerts antiamnesic effect on diazepam-induced anterograde amnesia in mice

    Neurochem. Res.

    (2011)
  • G.H. Du et al.

    Protective effects of salvianolic acid A against impairment of memory induced by cerebral ischemia-reperfusion in mice

    Yao Xue Xue Bao.

    (1995)
  • Cited by (42)

    • Design, synthesis and biological evaluation of pyranocarbazole derivatives against Alzheimer's disease, with antioxidant, neuroprotective and cognition enhancing properties

      2022, Bioorganic Chemistry
      Citation Excerpt :

      In general, 3-methoxy-4-methylphenylhydrazine hydrochloride (2) was easily prepared from commercially available 3-methoxy-4-methylaniline hydrochloride (1) by the reactions of diazotization and reduction. Compound 2 reacted with 4-tert-Butylcyclohexanone by the means of Borsche-Drechsel cyclization to give 3 [23,24]. The subsequent Pd/C-catalyzed dehydroaromatization of 3 afforded intermediate 4.

    • Salvianolic acid B induces browning in 3T3-L1 white adipocytes via activation of β3-AR and ERK signaling pathways

      2021, Journal of Functional Foods
      Citation Excerpt :

      Salvianolic acids are the most water-soluble compounds in S. miltiorrhiza, of which salvianolic acid A (Sal A) and salvianolic acid B (Sal B) are most abundantly found. Sal A possesses anti-oxidative (Du & Zhang, 1995), anti-apoptotic (Wang & Xu, 2005), and anti-inflammatory (Oh, Oh, Mun, Seo, & Lee, 2011) properties, and is reported to protect human SH-SY5Y neuroblastoma cells against H2O2-induced injury by increasing the stress tolerance ability (Zhang et al., 2012). Sal B has also been studied extensively, and is shown to have a wide range of pharmacological effects including anti-oxidation, apoptosis inhibition, coronary artery dilation, and aggregation platelet prevention (Wang et al., 2013; Ren et al., 2016).

    • Therapeutic targets of oxidative/nitrosative stress and neuroinflammation in ischemic stroke: Applications for natural product efficacy with omics and systemic biology

      2020, Pharmacological Research
      Citation Excerpt :

      The neuroprotective mechanisms could be attributed to inhibiting inflammatory responses, nitrotyrosine formation, and NF-κB signaling induction [170]. Sal A treatment also showed to attenuate eNOS uncoupling and inhibited ONOO− production in the ischemic brains in vivo, and prevented H₂O₂-mediated injury in cultured human SH-SY5Y neuroblastoma cells in vitro [173,174]. Sal A also inhibited the adhesion molecule ICAM-1 in endothelial cells and decreased the adhesion of granulocytes in vitro [175].

    • Preparation of salvianolic acid A by the degradation reaction of salvianolic acid B in subcritical water integrated with pH-zone-refining counter-current chromatography

      2016, Journal of Chromatography A
      Citation Excerpt :

      Sal B was proved to be a potential candidate for treatment of Alzheimeŕs disease [6], liver fibrosis [7], and traumatic brain injury [8]. Sal A was reported to have antioxidant [9], radical scavenging [10], neuroprotection [11], cardiovascular and cerebrovascular protection effects [12–14]. And in some respects, Sal A is more active than Sal B [15].

    View all citing articles on Scopus
    1

    Address: Qingdao Municipal Hospital, Qingdao 266011, PR China.

    2

    Address: Tianjin Institute of Pharmaceutical Research, 308 Anshan Xidao, Nankai District, Tianjin 300193, PR China.

    3

    Address: Center for Critical Illness Research, Lawson Health Research Institute, Department of Medicine and Pathology, University of Western Ontario, London, Canada.

    View full text